abstract |
The invention provides novel compounds having the general formula (I) wherein R 1 , X, Z l to Z 5 , L, n, the A ring, and the B ring, are as described herein, pharmaceutical compositions including the compounds and methods of using the compounds.Compounds (I) act as inhibitors of RIP1 kinase. |